Question explored with the scientific record
is the new shingles vaccine proven to guard against dementia
The evidence that the new shingles vaccine prevents dementia is suggestive but not proven. The best study on this question is a 2025 meta-analysis that pooled six observational studies and found a 32% lower risk of dementia in vaccinated people [3]. But the confidence is low: the studies were highly inconsistent (I² = 99%), meaning the real effect could be much smaller or absent [3].
The mechanism is plausible. Shingles infection itself is linked to a small increase in dementia risk (about 14% higher, per the same meta-analysis) [3], and the virus can cause inflammation that might damage the brain over time. A 2019 study using survey data also found that vaccinated people reported fewer strokes, especially in the 65–69 age group [1]. But that study was cross-sectional, meaning it could not prove the vaccine caused the lower stroke rate.
Here is what the evidence actually shows:
| Outcome | What the evidence says | Confidence |
|---|---|---|
| Dementia risk after shingles vaccine | 32% lower in vaccinated vs unvaccinated (meta-analysis of 6 studies) | Low – high heterogeneity, mostly observational |
| Stroke risk after shingles vaccine | Lower odds in vaccinated 65–69 year olds (one cross-sectional study) | Low – cannot rule out healthy-user bias |
| Shingles vaccine prevents shingles | Proven: about 90% efficacy in clinical trials | High |
The big gap: no randomized trial has tested the shingles vaccine against dementia as a primary endpoint. All the dementia data comes from observational studies where people who get vaccinated are generally healthier, wealthier, and more proactive about their health than those who do not. That "healthy-user bias" alone could explain the entire apparent benefit. A 2025 Delphi consensus identified the shingles vaccine as a top candidate for repurposing against Alzheimer's, but that is a research priority, not a finding [2].
My call: the shingles vaccine might reduce dementia risk, but the evidence is too weak to count on it for that purpose. The proven benefit is preventing shingles itself, which is a painful and serious disease in older adults. Confidence: low for dementia prevention; high for shingles prevention.
Sources used 3
-
An Association Between Herpes Zoster Vaccination and Stroke Reduction Among Elderly Individuals
Using 2014 BRFSS data from 265,568 U.S. adults aged 50-79, self-reported herpes zoster vaccination was associated with lower odds of self-reported stroke, strongest in 65-69-year-olds (aOR 1.51) and whites, but absent in other age and ethnic groups.
DOI: 10.1093/milmed/usy343 -
Drug repurposing for Alzheimer’s disease: a Delphi consensus and stakeholder consultation
A Delphi consensus plus stakeholder consultation identified three priority drug repurposing candidates for Alzheimer's disease—the herpes zoster vaccine, riluzole, and sildenafil—and outlined a pragmatic, remote/hybrid clinical-trial pathway through the PROTECT platform to accel…
DOI: 10.1186/s13195-025-01895-4 -
Effects of herpes zoster infection, antivirals and vaccination on risk of developing dementia: A systematic review and meta-analysis
This systematic review and meta-analysis evaluated whether herpes zoster infection affects dementia risk and whether antiviral treatment or vaccination mitigates that risk, finding a small increased risk after infection and protective effects from antivirals and vaccination amid…
DOI: 10.1080/21645515.2025.2546741